Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 4Phase NA 2Phase 1/2 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Unknown 6Recruiting 4Not yet recruiting 3Completed 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Locally Advanced Breast Cancer 1HER2-positive Metastatic Breast Cancer 1Breast Neoplasms 1Breast Cancer Invasive 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × pyrotinib × Clear all
NCT05910398 2025-11-18

CORINNE-PI

RenJi Hospital

Phase 3 Recruiting
488 enrolled
Breast

Breast Cancer Invasive

NCT04254263 2025-09-11

ATP

RenJi Hospital

Phase 3 Recruiting
316 enrolled
Breast

Locally Advanced Breast Cancer

NCT06278870 2024-02-26

Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Recruiting
312 enrolled
Breast

HER2-positive Metastatic Breast Cancer

NCT04646759 2020-11-30

Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Recruiting
516 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡